why choose us

First received: May 30, 2023

Clinical Trial: Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Lactation Study in Healthy Adult Lactating Female Subjects One to Six Months Post-Partum to Evaluate the Pharmacokinetics and Safety of Ubrogepant and Atogepant

Brief Summary: This study will assess adverse events and compare how ubrogepant and atogepant tablets move through the body of healthy adult lactating female participants.Ubrogepant and atogepant are approved drugs for treatment of migraine in adults.Participants will be assigned to one of the 2 treatment arms to receive atogepant or ubrogepant.Approximately 24 healthy adult lactating female participants will be enrolled at 3 sites in the United StatesParticipants will receive oral tablets of ubrogepant or atogepant on Day 1 and…

Read more